Stocks
Biodesix Lifts 2026 Revenue Outlook to $108M-$114M
Biodesix (BDSX) raises its 2026 revenue forecast to $108M-$114M, driven by accelerated Q1 growth and expanded margins, targeting sustained adjusted EBITDA profitability.
#revenue forecast 3 articles
Stocks
Beta Bionics Projects $131M Revenue, Boosts Margin Outlook
Beta Bionics forecasts $131M-$136M in 2026 revenue and raises its gross margin outlook to 57.5%-59.5%, signaling strong financial projections.
Stocks
Gloo Targets $190M Revenue, Q4 2026 Profitability After EMD Deal
Gloo Holdings projects $190 million in 2026 revenue and aims for adjusted EBITDA profitability by Q4 2026, following a strong Q4 fiscal...